| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adjuvant chemotherapy after preoperative chemoradiotherapy for rectal cancer
|
Kanyilmaz, G.
|
|
|
26 |
11 |
p. 2352
|
artikel
|
| 2 |
A phase I, dose-escalation study of volasertib combined with nintedanib in advanced solid tumors
|
de Braud, F.
|
|
|
26 |
11 |
p. 2341-2346
|
artikel
|
| 3 |
A phase III randomized trial of adding topical nitroglycerin to first-line chemotherapy for advanced nonsmall-cell lung cancer: the Australasian lung cancer trials group NITRO trial
|
Davidson, A.
|
|
|
26 |
11 |
p. 2280-2286
|
artikel
|
| 4 |
A randomized, controlled phase III trial of nab-Paclitaxel versus dacarbazine in chemotherapy-naïve patients with metastatic melanoma
|
Hersh, E.M.
|
|
|
26 |
11 |
p. 2267-2274
|
artikel
|
| 5 |
A randomized phase II study comparing paclitaxel–carboplatin–bevacizumab with or without nitroglycerin patches in patients with stage IV nonsquamous nonsmall-cell lung cancer: NVALT12 (NCT01171170) †
|
Dingemans, A.-M. C.
|
|
|
26 |
11 |
p. 2286-2293
|
artikel
|
| 6 |
Assessment of anticancer-treatment outcome in patients with metastatic castration-resistant prostate cancer—going beyond PSA and imaging, a systematic literature review
|
Schmid, S.
|
|
|
26 |
11 |
p. 2221-2247
|
artikel
|
| 7 |
Carfilzomib and pomalidomide in patients with relapsed and/or refractory multiple myeloma with baseline risk factors
|
Dimopoulos, M.A.
|
|
|
26 |
11 |
p. 2247-2256
|
artikel
|
| 8 |
Central adiposity, obesity during early adulthood, and pancreatic cancer mortality in a pooled analysis of cohort studies
|
Genkinger, J.M.
|
|
|
26 |
11 |
p. 2257-2266
|
artikel
|
| 9 |
Corrections to “REBECA: a phase I study of bevacizumab and whole-brain radiation therapy for the treatment of brain metastasis from solid tumours”
|
Lévy, C.
|
|
|
26 |
11 |
p. 2359
|
artikel
|
| 10 |
Development and validation of a nomogram to predict survival in incurable cachectic cancer patients on home parenteral nutrition
|
Bozzetti, F.
|
|
|
26 |
11 |
p. 2335-2340
|
artikel
|
| 11 |
Disease characteristics, treatment patterns, and outcomes of follicular lymphoma in patients 40 years of age and younger: an analysis from the National Lymphocare Study †
|
Casulo, C.
|
|
|
26 |
11 |
p. 2311-2317
|
artikel
|
| 12 |
Editorial Board
|
|
|
|
26 |
11 |
p. ii-iii
|
artikel
|
| 13 |
Era-by-era improvement in survival for elderly patients with Hodgkin lymphoma; outcome data from a large population-based cohort
|
Bishton, M.J.
|
|
|
26 |
11 |
p. 2356-2357
|
artikel
|
| 14 |
Evaluation of tumor-infiltrating lymphocytes in breast cancer; proposal of a simpler method
|
Hida, A.I.
|
|
|
26 |
11 |
p. 2351
|
artikel
|
| 15 |
Hemorrhagic cystitis in a patient without a past history of radiation therapy who was treated with cabazitaxel for CRPC
|
Kosaka, T.
|
|
|
26 |
11 |
p. 2355-2356
|
artikel
|
| 16 |
High burden of copy number alterations and c-MYC amplification in prostate cancer from BRCA2 germline mutation carriers
|
Castro, E.
|
|
|
26 |
11 |
p. 2293-2300
|
artikel
|
| 17 |
Histologic transformation in marginal zone lymphomas †
|
Conconi, A.
|
|
|
26 |
11 |
p. 2329-2335
|
artikel
|
| 18 |
Is chemotherapy still an option in the treatment of melanoma?
|
Carlino, M.S.
|
|
|
26 |
11 |
p. 2203-2204
|
artikel
|
| 19 |
Life expectancy of young adults with follicular lymphoma
|
Conconi, A.
|
|
|
26 |
11 |
p. 2317-2322
|
artikel
|
| 20 |
Long-term exposure to circulating platinum is associated with late effects of treatment in testicular cancer survivors
|
Boer, H.
|
|
|
26 |
11 |
p. 2305-2310
|
artikel
|
| 21 |
Maintenance rituximab after autologous stem cell transplantation in patients with mantle cell lymphoma
|
Graf, S.A.
|
|
|
26 |
11 |
p. 2323-2328
|
artikel
|
| 22 |
Management of advanced prostate cancer
|
von Eyben, F.
|
|
|
26 |
11 |
p. 2354
|
artikel
|
| 23 |
New life for retrospective study in the precision oncology era
|
Orlandi, A.
|
|
|
26 |
11 |
p. 2352-2353
|
artikel
|
| 24 |
Oncology 2020: a drug development and approval paradigm
|
Dhingra, K.
|
|
|
26 |
11 |
p. 2347-2350
|
artikel
|
| 25 |
Randomized phase III trial of treatment duration for oral uracil and tegafur plus leucovorin as adjuvant chemotherapy for patients with stage IIB/III colon cancer: final results of JFMC33-0502
|
Sadahiro, S.
|
|
|
26 |
11 |
p. 2274-2280
|
artikel
|
| 26 |
RandomizEd phase II trial of Sunitinib four weeks on and two weeks off versus Two weeks on and One week off in metastatic clear-cell type REnal cell carcinoma: RESTORE trial
|
Lee, J.L.
|
|
|
26 |
11 |
p. 2300-2305
|
artikel
|
| 27 |
Reply to the letter to the editor ‘Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015’ by Gillessen et al.
|
Gillessen, S.
|
|
|
26 |
11 |
p. 2354-2355
|
artikel
|
| 28 |
Reply to the letter to the editor ‘New life for retrospective study in the Precision Oncology Era’ by Orlandi et al.
|
Pietrantonio, F.
|
|
|
26 |
11 |
p. 2353
|
artikel
|
| 29 |
Should de-escalation of bone-targeting agents be standard of care for patients with bone metastases from breast cancer? A systematic review and meta-analysis
|
Ibrahim, M.F.K.
|
|
|
26 |
11 |
p. 2205-2213
|
artikel
|
| 30 |
Table of Contents
|
|
|
|
26 |
11 |
p. iv-vi
|
artikel
|
| 31 |
The ESMO magnitude of clinical benefit scaling tool: from theory to practice
|
Hartmann, M.
|
|
|
26 |
11 |
p. 2357-2358
|
artikel
|
| 32 |
Why has active immunotherapy not worked in lung cancer?
|
Thomas, A.
|
|
|
26 |
11 |
p. 2213-2220
|
artikel
|
Tijdschrift beschrijving